ATH-04

N/A

Report date: 2023/04/10 14:28:55

Base Information

Drug NameATH-04
Drug Alias NameAFFITOPE AT04A+adjuvantATH-04Affitope AT04A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionProprotein convertase subtilisin kexin type 9 inhibitors
TargetsProprotein convertase subtilisin kexin type 9
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAffiris Ag
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAtherosclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A